Highbridge Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-20,000
Closed -$2.15M 453
2023
Q2
$2.06M Buy
+20,000
New +$2.11M 0.09% 105
2017
Q3
Sell
-276,472
Closed -$3.28M 1915
2017
Q2
$3.28M Sell
276,472
-1,268,697
-82% -$15.8M 0.05% 370
2017
Q1
$22.8M Buy
1,545,169
+967,927
+168% +$15.7M 0.33% 76
2016
Q4
$9.34M Buy
577,242
+184,051
+47% +$3.34M 0.17% 163
2016
Q3
$7.13M Sell
393,191
-384,280
-49% -$7.51M 0.11% 204
2016
Q2
$12.8M Sell
777,471
-712,769
-48% -$11.5M 0.21% 135
2016
Q1
$24.7M Sell
1,490,240
-160,876
-10% -$2.81M 0.41% 59
2015
Q4
$35.8M Buy
1,651,116
+1,595,364
+2,862% +$31.1M 0.55% 31
2015
Q3
$1.1M Buy
55,752
+29,648
+114% +$937K 0.02% 736
2015
Q2
$907K Sell
26,104
-355,133
-93% -$10.8M 0.01% 756
2015
Q1
$9.9M Buy
+381,237
New +$6.99M 0.14% 201

Other funds holding HZNP